A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine

NCT04437433 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
186
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AbbVie